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MUTANT SCREEN REPORT
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ABSTRACT Nonmuscle myosin type II (Myo1p) is required for cytokinesis in the budding yeast Saccharomyces
cerevisiae. Loss of Myo1p activity has been associated with growth abnormalities and enhanced sensitivity to
osmotic stress, making it an appealing antifungal therapeutic target. The Myo1p tail-only domain was previously
reported to have functional activity equivalent to the full-length Myo1p whereas the head-only domain did not.
Since Myo1p tail-only constructs are biologically active, the tail domain must have additional functions beyond its
previously described role in myosin dimerization or trimerization. The identification of new Myo1p-interacting
proteins may shed light on the other functions of the Myo1p tail domain. To identify novel Myo1p-interacting
proteins, and determine if Myo1p can serve as a scaffold to recruit proteins to the bud neck during cytokinesis, we
used the integrated split-ubiquitin membrane yeast two-hybrid (iMYTH) system. Myo1p was iMYTH-tagged at its
C-terminus, and screened against both cDNA and genomic prey libraries to identify interacting proteins. Control
experiments showed that the Myo1p-bait construct was appropriately expressed, and that the protein colocalized
to the yeast bud neck. Thirty novel Myo1p-interacting proteins were identified by iMYTH. Eight proteins were
confirmed by coprecipitation (Ape2, Bzz1, Fba1, Pdi1, Rpl5, Tah11, and Trx2) or mass spectrometry (AP-MS)
(Abp1). The novel Myo1p-interacting proteins identified come from a range of different processes, including
cellular organization and protein synthesis. Actin assembly/disassembly factors such as the SH3 domain protein
Bzz1 and the actin-binding protein Abp1 represent likely Myo1p interactions during cytokinesis.
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The Saccharomyces cerevisiae myosin type II (Myo1p) is found in the
contractile ring that contributes to its function in cell division coupled
with chitin synthase 2 driven membrane ingression (Bi et al. 1998;
VerPlank and Li 2005; Schmidt et al. 2002). Myo1p is a large protein
(223.6 kDa) that consists of a globular N-terminal head domain [amino
acids (aa) 1–800], and a long tail (aa 850–1928). The globular head binds
to filamentous actin and ATP. The tail domain has been predicted to
adopt a coiled-coil conformation with breaks (May et al. 1998). Un-
expectedly, Myo1p was found to function in cytokinesis as a tail-only
domain (Tolliday et al. 2003; Lord et al. 2005; Lister et al. 2006), suggest-
ing that the N-terminal domain power-stroke function is not an essen-
tial feature of Myo1p. Furthermore, a minimum localization domain
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(MLD) identified in the terminal 1000 aa, whichwas previously associated
with Myo1p oligomerization, appears to provide additional biological
activity, and possibly serves as a site for the recruitment of the cytokinesis
machinery and/or to signal for cell division (Lister et al. 2006). Previous
yeast two-hybrid experiments (Drees et al. 2001; Wang et al. 2012), and
TAP-tag protein copurification experiments (Gavin et al. 2002) identified
multiple putative Myo1p-interacting proteins, but shed little light on the
role of the Myo1p tail as a potential platform for the recruitment of
proteins that may regulate cytokinesis. Earlier studies relied heavily on
the recovery of soluble proteins, which the Myo1p-protein interactions
were likely biased against. In this study, we used a modified integrated
split-ubiquitin membrane yeast two-hybrid (iMYTH) technique to search
for Myo1p interactions with associated proteins (Stagljar et al. 1998;
Paumi et al. 2007; Snider et al. 2010, 2013) thatmay support the function
of the C-terminal region of Myo1p at the bud neck during cytokinesis.
MATERIALS AND METHODS
Yeast strains and culture conditions
All yeast strains were grown at 30 in YPD broth while shaking at
225 rpm (Table 1). Artificial bait L40, Myo1 L40 L2, and Myo1 L40
L3 strains were maintained on YPD or YPD +200 mg/ml of G418 with
2% agar medium, and were transferred to synthetic dropout medium
without tryptophan to select for retention of prey plasmids during
screening. Myo1-GFP strains were maintained in synthetic medium
lacking histidine. Strains used in this study are available upon request.
Bait construction
To construct the bait strain for iMYTH experiments, we followed the
protocol described by Snider et al. 2010. Briefly, to generate Myo1 L40
L2 and Myo1 L40 L3-containing strains (Figure 1A), the Myo1-
MYTH 59 (CGAAAAATATTGATAGTAACAATGCACAGAG
TAAAATTTTCAGTATGTCGGGGGGATCCCTCC) and Myo1-
MYTH 39 (GGTGAAAGAGTTCATGCCACTTAGTATATAACGCTC
GTGTCGTCACTATAGGGAGACCGGCAG) primers were used to
PCR-amplify a Cub-LexA-VP16 KanMX, or Cub-YFP-LexA-VP16
KanMX, cassette from L2 or L3 plasmids, respectively (Snider et al.
2010). The L40 yeast reporter strain was transformed with the cas-
sette, and transformants were selected with YPD + 200 mg/mL
G418. For bait validation, fluorescence microscopy (Figure 1B) and
NubG/I self-activation tests (Figure 2) were performed.
Library transformation, bait-dependency test, and
interactome generation
Myo1 L40 was transformedwith NubG-X genomic and cDNA libraries
provided by the Stagljar laboratory. Positive clones were selected using
synthetic dropout medium without tryptophan (SD–W). The plasmids
recovered from the transformed yeast cells were partially sequenced
(300 bp) to identify the encoded gene, and their interaction with the
bait protein was reconfirmed using a bait dependency test under selec-
tion using synthetic dropoutmediumwithout tryptophan and histidine
(SD–WH) (Snider et al. 2010). The exact size of the prey cDNAs was
not determined. The A0287 strain used as a negative control in the bait
dependency test expresses a Mata signal sequence and the transmem-
brane domain of human T-cell surface glycoprotein CD4 fused to the
C-terminal ubiquitin domain plus transcription factors LexA and
VP16. The positive interactors were classified according to their Gene
Ontology (GO; http://geneontology.org/) functions and previously re-
ported physical and genetic interactions. The Biological General Re-
pository for Interaction Datasets (BioGRID; http://thebiogrid.org/), a
curated database of yeast protein–protein and genetic interactions, was
used to identify previously reported interactions. Cytoscape (http://
www.cytoscape.org/) was used to generate two-dimensional interaction
maps for visualization of these interactions.
In vitro validation of the Myo1p iMYTH interactors
by coimmunoprecipitation
To capture the Myo1p-interacting proteins for in vitro validation of the
physical interactions identified by iMYTH, and for their subsequent
identification by coimmunoprecipitation (coIP), we employed a mod-
ified pull-down approach (Babu et al. 2009) using a TAP epitope fused
n Table 1 Strains used in this study
Strain Genotype Source
L40 MATa HIS3 200 trp1-901 leu2-3, 112 ade2 LYS2::(lexAop)4-HIS3 URA3::
(lexAop)8-lacZ GAL4
Stagljar laboratory
Artificial bait in L40 (A0287) MATa HIS3 200 trp1-901 leu2-3, 112 ade2 LYS2::(lexAop)4-HIS3 URA3::
(lexAop)8-lacZ GAL4 Mata-CD4(TM)::(Cub-YFP-lexA-VP16-KanMX)
Stagljar laboratory
Myo1 L40 L2 MATa HIS3 200 trp1-901 leu2-3, 112 ade2 LYS2::(lexAop)4-HIS3 URA3::
(lexAop)8-lacZ GAL4 MYO1-(Cub-lexA-VP16-KanMX)
This study
Myo1 L40 L3 MATa HIS3 200 trp1-901 leu2-3, 112 ade2 LYS2::(lexAop)4-HIS3 URA3::
(lexAop)8-lacZ GAL4 MYO1-(Cub-YFP-lexA-VP16-KanMX)
This study
BY4741 MATa his3delta1 leu2delta0 met15delta0 ura3delta0 ATCC
Myo1-GFP MATa leu2delta0 met15delta0 ura3delta0 MYO1-(GFP-His3MX6) ThermoFisher
Myo1-TAP (orf)-HA MATa leu2delta0 met15delta0 ura3delta0 MYO1::(CBP- This study
TEV -ZZ-His3MX6) pBG1805-(orf)-His6-HA-3C-ZZp
Figure 1 (A) Bar diagram representing the expressed Myo1p bait
with iMYTH tags integrated by homologous recombination at the
C-terminus. The iMYTH tag consists of the C-terminal half of ubiquitin
(Cub; labeled as C), and a transcription factor (labeled as T) comprised
of the Escherichia coli LexA DNA-binding protein, and the herpes
simplex virus VP16 transcriptional activation domain (L2 tag). The L3
variant of the tag contains an YFP molecule (labeled as Y) between C
and T. The head domain and the MLD are indicated by lines. (B) In vivo
localization of the Myo1 bait protein. YFP localization of Myo1p bait
protein containing the L3 variant of the tag at the bud-neck in L40
cells. This confirms expression of Myo1p without disruption of function
due to mutations and ensures inframe insertion of the CYT (L3) tag.
1470 | E. Santiago et al.
to theMyo1pC-terminus (Myo1-TAP). TheMyo1-TAPbait strain was
transformed with a full-length prey protein in expression vector
BG1805, a URA3multicopy 2 m plasmid containing a GAL1 promoter
(Gelperin et al. 2005), using the standard lithium acetate procedure
(Gietz and Woods 2006). The Myo1 protein was captured using the
calmodulin-binding peptide in the TAP epitope. Briefly, 40 ml of cul-
ture was grown for 2 d in YPD at 30 at 200 rpm. Subsequently, the
cells were centrifuged at 3000 rpm for 3 min, and washed twice with
20 ml IPLB buffer (20 mM Hepes KOH, pH 7.4, 150 mM KOAc,
2 mMMg(Ac)2, 2 mMCaCl2, and 10% glycerol). For plasmid expres-
sion, cells were resuspended in YP-GAL, and incubated for 2–4 hr. The
yeast cells were lysed with breaking buffer (IPLB buffer plus 1%Triton-
X100 and 1· Protease inhibitor cocktail 1 from Calbiochem (EMD,
#539131), and disrupted with glass beads by vortexing at maximum
speed for 5 min. Cell lysates were cleared by centrifugation at
4000 rpm for 4 min. For protein isolation, 50 mL of calmodulin beads
were mixed with 700 mL of the cell lysate in a microcentrifuge tube,
and placed in a rotator for 2 hr at 4. After incubation, the beads were
centrifuged at 5000 rpm for 2 min at 4. The resulting supernatant
Figure 2 A self-activation test for Myo1p bait construct. The Myo1p
bait is intact and does not self-activate. Interactions and growth on
selective medium composed of synthetic dropout medium containing
2% dextrose, and lacking both tryptophan and histidine (SD–WH) (bot-
tom two panels), is observed only using the positive control NubI-
fusions to the Ost1 and Fur4 proteins. Negative control preys, Ost1
and Fur4 proteins fused to NubG did not show interaction and growth
on selective SD–WH medium. All transformed cells grew on SD–W
media (synthetic dropout medium containing 2% dextrose and lacking
tryptophan) (top panels), which selects only for the presence of control
plasmids (and not interaction). Each row represents an individual col-
ony of the Myo1p L40 L2 strain transformed with the indicated control
prey plasmid. Colonies were resuspended in 0.9% NaCl, serially di-
luted (left to right = 100, 1021, 1022, and 1023), and spotted onto
selective medium.
Figure 3 Confirmed iMYTH Myo1p hits. The top eight out of 30
confirmed iMYTH hits are shown. The remaining hits have been
included in Figure S1. In the top eight rows, growth of Myo1 L40 strain
containing the prey protein was observed on synthetic dropout me-
dium containing 2% dextrose and lacking both tryptophan and histi-
dine (SD–WH), while no growth was observed for corresponding
A0287 strain, thereby confirming the specificity of each bait–prey in-
teraction. The asterisk identifies Abp1p, the prey protein confirmed by
AP-MS. The remaining 7 iMYTH hits were confirmed by coIP. The
bottom four rows show growth in Ost1-NubI and Fur4-NubI positive
control preys (described in Figure 2).
n Table 2 Myo1p-interacting proteins validated by coimmunoprecipitation
Gene name Systematic Name Description (According to SGD, http://www.yeastgenome.org/)
APE2 YKL157W Aminopeptidase yscII; may have a role in obtaining leucine from dipeptide substrates; APE2 has a
paralog, AAP1, that arose from whole genome duplication
BZZ1 YHR114W SH3 domain protein implicated in regulating actin polymerization; able to recruit actin polymerization
machinery through its SH3 domains; colocalizes with cortical actin patches and Las17p; interacts
with type I myosins
FBA1 YKL060C Fructose 1,6-bisphosphate aldolase; required for glycolysis and gluconeogenesis; catalyzes conversion
of fructose 1,6 bisphosphate to glyceraldehyde-3-P and dihydroxyacetone-P; locates to
mitochondrial outer surface upon oxidative stress; N-terminally propionylated in vivo
PDI1 YCL043C Protein disulfide isomerase; multifunctional protein of ER lumen, essential for formation of disulfide
bonds in secretory and cell-surface proteins, unscrambles non-native disulfide bonds; key regulator
of Ero1p; forms complex with Mnl1p, which has exomannosidase activity, processing unfolded
protein-bound Man8GlcNAc2 oligosaccharides to Man7GlcNAc2, promoting degradation in
unfolded protein response; PDI1 has a paralog, EUG1, that arose from whole genome duplication
RPL5 YPL131W Ribosomal 60S subunit protein L5; nascent Rpl5p is bound by specific chaperone Syo1p during
translation; homologous to mammalian ribosomal protein L5 and bacterial L18; binds 5S rRNA and
is required for 60S subunit assembly
TAH11 YJR046W DNA replication licensing factor; required for prereplication complex assembly
TRX2 YGR209C Cytoplasmic thioredoxin isoenzyme; part of thioredoxin system that protects cells against oxidative
and reductive stress; forms LMA1 complex with Pbi2p; acts as a cofactor for Tsa1p; required for
ER-Golgi transport and vacuole inheritance; with Trx1p, facilitates mitochondrial import of small
Tims (Tim9p, Tim10p, and Tim13p) by maintaining them in reduced form; abundance increases
under DNA replication stress; TRX2 has a paralog, TRX1, that arose from whole genome duplication
SGD, Saccharomyces genome database; ER endoplasmic reticulum.
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was removed and the beads were washed six times with 800 mL of cold
IPLB. The beads were then resuspended in an equal volume of IPLB
and denatured with 2· Laemmli dye at 95. The denatured proteins
were electrophoresed in a 10% SDS-PAGE gel, and western blot anal-
ysis was performed using anti-HA probe (Y-11; Santa Cruz Biotech-
nology). HRP-anti-rabbit antibody and enhanced chemiluminescent
signal detection reagents (Pierce) were used to visualize the prey protein
bands.
In vitro validation of the Myo1p iMYTH interactors by
affinity-purification-mass spectrometry (AP-MS)
The affinity capture of GFP tagged to the Myo1 C-terminus (Myo1-
GFP), and subsequent analysis by MS was also used for in vitro
validation of iMYTH Myo1p interacting proteins. Briefly, 40 ml of
Myo1-GFP and BY4741 cultures were grown overnight in YPD. The
cells were harvested at 3000 rpm for 5 min. The pellet was resus-
pended in 1 ml IPLB + 1· Protease inhibitor cocktail 1. The cells
were disrupted via 5 min vortexing with an equal volume of glass
beads. The supernatant was added to 50 mL Miltenyi mbeads (Anti-
GFP, #130-094-252), and incubated on ice with rotation for 30 min.
Miltenyi magnetic bead columns were washed prior to use with
200 mL IPLB. Next, the lysate was added, and the beads subsequently
washed three times with 800 mL Native IP buffer (50 mM Tris,
pH 7.5; 150 mM NaCl; 2.5 mM EDTA), and two times with 500 mL
of the same buffer. The bound proteins were released with 100 mL of
elution buffer (2 M Urea, 50 mM Tris, pH 7.5, 5 mM Chloraceta-
mide). Tryptic digestion for MS was performed with 5 mg/ml Trypsin
gold (Promega, #V5280). The peptides were selected and desalted, using
ZipTip with 0.2 mL C18 resin (Zip tips, EMD Millipore
#ZTC18M960). The protein isolations were conducted in triplicate.
Each sample was subjected to analysis with an Orbitrap Elite mass
spectrometer to generate MS/MS spectra. The results obtained were
matched against a yeast protein sequence database using SEQUEST
search engine and scored according to the number of unique peptides
identified and the STATQUEST algorithm. Matches were considered
valid if they contained more than two unique peptide fragments and
matches of . 95% probability.
RESULTS AND DISCUSSION
The iMYTH system is a powerful tool for screening protein–protein
interactions, both in vivo and in the natural cellular environment
where these interactions are expected to occur (Paumi et al. 2007;
Snider et al. 2010). The advantage of iMYTH is that it may detect
weak protein–protein interactions, and/or temporally regulated in-
teractions, which may not be detected by conventional pull-down
methods. The S. cerevisiae wild-type myosin type II (Myo1p) local-
izes to the bud-neck during cell division (Bi et al. 1998); the Myo1p
fusion protein used as the bait in this study was also shown to
localize precisely to this site (Figure 1B). Another advantage of
iMYTH is that the bait, in this case the Myo1 fusion protein, is
localized in its natural cellular environment instead of an artificial
one, such as the nucleus, as in other classical yeast two-hybrid
systems (Drees et al. 2001). Another valuable feature of the iMYTH
system is that the bait protein is expressed by its native promoter so
that the protein levels are not artificially elevated. Furthermore, the
system is monitored for self-activation of the bait modules through
the use of positive and negative control preys (Figure 2), helping
reduce the incidence of false positive results.
In this study, we used a modified iMYTH screen to identify
Myo1p-interacting proteins. A total of 30 initial hits were identified
(Supplemental Material, Figure S1), all of which passed a secondary
bait dependency test. Eight of these hits were confirmed by coIP or
AP-MS (Figure 3, Table 2, and Table 3, respectively), and were
therefore considered as highly reliable Myo1p-interacting proteins.
A null mutation of ABP1 did not visibly alter the bud neck locali-
zation of a Myo1p-YFP fusion protein (data not shown). Haploid
null mutations of FBA1, PDI1, RPL5, and TAH11 are lethal and were
not tested. Null strains of TRX2, APE2, and BZZ1 were not available
for testing.
The high number of validated hits identified (26.7%) demonstrated
the value of iMYTH as a robust high-throughput screening tool for the
discovery of novel target proteins with important regulatory functions.
None of the 30 Myo1p iMYTH interactors identified in this study
(Figure S1) were previously reported in the Saccharomyces Genome
Database (SGD; http://www.yeastgenome.org/) (see summary in Figure
4). Furthermore, we did not identify other expected interactors in this
screen that were previously reported in the SGD, such as actin (ACT1),
or the myosin light chains (MLC1 andMLC2) (Drees et al. 2001; Gavin
et al. 2002; Krogan et al. 2006). This may have been due to the physical
constraints of the iMYTH construct, where ACT1 interacts with the
actin-binding domain at the N-terminal region of Myo1p, whileMLC1
andMLC2 bind to the neck region proximal to the ATPase domain of
Myo1p. Nonetheless, when the ACT1 gene was cloned in the prey
plasmid BG1805, and coexpressed with the Myo1p bait, it was con-
firmed to interact with Myo1p in coIP assays (Figure S2A). Therefore,
the absence of clones encoding Act1p, and possibly other known
n Table 3 Myo1p-interacting proteins validated by affinity purification-mass spectrometry
Gene
name
Systematic
name
Negative control MYO1 Replicate 1 MYO1 Replicate 2 MYO1 Replicate 3
Total
Peptides Probability (%)
Total
Peptides Probability (%)
Total
Peptides Probability (%)
Total
Peptides Probability (%)
ABP1 YCR088W 2 98.97 3 99.58 5 99.58 4 99.58
Exclusive unique peptide count for new Myo1p interactors identified by iMYTH and validated by affinity purification-mass spectrometry.
Figure 4 Venn diagram showing the 30 novel Myo1p-interacting
partners identified by iMYTH, AP-MS, and coIP. These 30 Myo1p-
interacting proteins (purple) have not been reported previously among
the 103 Myo1p interactors listed in the SGD. Seven of the 30 novel
iMYTH-positive interactors were validated by coIP (teal); one of the 30
was validated by AP-MS experiments (green). None of these Myo1p-
interacting proteins were validated by all three methods. Therefore, a
total of eight were classified as confirmed positive Myo1p interactors.
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Myo1p-interacting proteins, in our iMYTH screen may have been
caused by a low representation of these clones in the prey library.
Cloning and expression of the individual genes in a prey vector is
therefore the recommended approach to validate these and other re-
ported Myo1p-interacting proteins. On the other hand, other known
interactors of Myo1p that were missed, such as Mlc1p, Mlc2p, Bni5p,
and Kar2p, as well as Act1p, were reconfirmed by our AP-MS exper-
iments (Table 4). Therefore, the iMYTH method was capable of iden-
tifying different types of protein–protein interactions that are not
stabilized under the conditions employed in traditional capture meth-
ods such as AP-MS. In this regard, the coIP assay strategy used here,
coupled with detection by Western blot, proved to be a more effective
method for confirmation of iMYTH hits.
AP-MS analysis of Myo1p-GFP pull downs—a method capable of
pulling down large protein complexes attached to Myo1p irrespective
of their site of interaction within the protein—generated 49 Myo1p
physical interactors with.2 unique (present at least in one of the three
replicate purifications), statistically significant peptides (.90%) (Table
S1). Bni5, a septin protein required for cytokinesis in yeast (Lee et al.
2002) that was previously reported to interact with Myo1p (Schneider
et al. 2013), is among the five proteins reconfirmed by our study (Table
4). To summarize our findings, a proposed interaction network incor-
porating the eight novel Myo1p-interacting proteins confirmed in this
study is presented in Figure 5.
Abp1p is an actin-binding protein of the cortical actin cytoskeleton
that is important for activation of the Arp2/3 complex that plays a key
role in actin cytoskeleton organization and inhibits barbed-end actin
filament elongation (Michelot et al. 2013). Given its known function in
organization of the actin cortical cytoskeleton, we propose that Abp1p
could be associated with the process of disassembly of the actin ring as it
contracts during cytokinesis. The confirmation of Bzz1p as a Myo1p-
interacting protein by both iMYTH and coIP places another protein
implicated in regulating actin polymerization (Soulard et al. 2002),
together with Myo1p potentially at the bud neck. These results support
the possibility that Abp1p and Bzz1p with Bni5p (as reported previ-
ously by Schneider et al. 2013) may function together withMyo1p as
part of a complex to regulate actin filament dynamics at the cyto-
kinetic ring. Going forward, it will be valuable to map the sites of
iMYTH interaction between Myo1p and the recovered protein set,
and to investigate the functional consequences of direct and indirect
associations revealed by this study.
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n Table 4 Exclusive unique peptide count for Myo1p physical interactors previously reported in the SGD and confirmed by affinity
purification-mass spectrometry in this study
Gene
name
Systematic
name
Negative control MYO1 Replicate 1 MYO1 Replicate 2 MYO1 Replicate 3
Total
Peptides Probability (%)
Total
Peptides Probability (%)
Total
Peptides Probability (%)
Total
Peptides Probability (%)
MLC1 YGL106W 0 0 15 99.58 6 99.58 4 86.03
MLC2 YPR188C 0 0 33 99.58 41 99.58 32 99.58
BNI5 YNL166C 1 96.08 2 99.58 3 99.58 5 99.58
KAR2 YJL034W 2 96.57 2 96.12 5 99.58 3 98.17
ACT1 YFL039C 5 99.58 34 99.58 17 99.58 14 99.58
Figure 5 Proposed network of Myo1p-interacting
proteins identified by iMYTH, coIP, and AP-MS. A
Myo1-TAP construct was used as the bait protein
to confirm seven novel Myo1p-interacting proteins
by subsequent coIP assays. Abp1p, also a novel
interactor, was confirmed by AP-MS as listed in
Table 2 and Table 3, respectively. Previously re-
ported physical interactors of Myo1p: Mlc1p,
Mlc2p, Bni5p, Kar2p, and Act1p were confirmed
by AP-MS (see Table 4).
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